Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Barbara Baudner"'
Autor:
Donatello Laera, Camilla Scarpellini, Simona Tavarini, Barbara Baudner, Agnese Marcelli, Carlo Pergola, Malte Meppen, Derek T. O’Hagan
Publikováno v:
Vaccines, Vol 11, Iss 1, p 155 (2023)
Although aluminium-based vaccines have been used for almost over a century, their mechanism of action remains unclear. It is established that antigen adsorption to the adjuvant facilitates delivery of the antigen to immune cells at the injection site
Externí odkaz:
https://doaj.org/article/bde4b3d88f134f58a8bbf43e489a53f6
Autor:
Mariagrazia Pizza, Mickaël Desvaux, Grégory Jubelin, Juliette Vinot, Barbara Baudner, Ugo D'Oro, Annick Bernalier-Donadille, Cecilia Buonsanti, Ilham Naili
Publikováno v:
Vaccine
Vaccine, 2019, 37 (2), pp.314-324. ⟨10.1016/j.vaccine.2018.10.008⟩
Vaccine, Elsevier, 2019, 37 (2), pp.314-324. ⟨10.1016/j.vaccine.2018.10.008⟩
Vaccine, 2019, 37 (2), pp.314-324. ⟨10.1016/j.vaccine.2018.10.008⟩
Vaccine, Elsevier, 2019, 37 (2), pp.314-324. ⟨10.1016/j.vaccine.2018.10.008⟩
International audience; Emergence and dissemination of multidrug resistance among pathogenic Escherichia coli have posed a serious threat to public health across developing and developed countries. In combination with a flexible repertoire of virulen
Autor:
Daniele Veggi, Derek T. O'Hagan, Ilaria Ferlenghi, Yvonne Perrie, Signe Tandrup Schmidt, Giulia Anderluzzi, Robert Cunliffe, Stuart Woods, Barbara Baudner, Craig W. Roberts
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 330
A range of cationic delivery systems have been investigated as vaccine adjuvants, though few direct comparisons exist. To investigate the impact of the delivery platform, we prepared four cationic systems (emulsions, liposomes, polymeric nanoparticle
Autor:
Gustavo Lou, Michela Brazzoli, Russell Johnson, Barbara Baudner, Yvonne Perrie, Derek T. O'Hagan, Giulia Anderluzzi, Simona Gallorini
Publikováno v:
Vaccines
Volume 8
Issue 2
Vaccines, Vol 8, Iss 212, p 212 (2020)
Volume 8
Issue 2
Vaccines, Vol 8, Iss 212, p 212 (2020)
messenger RNA (mRNA)-based vaccines combine the positive attributes of both live-attenuated and subunit vaccines. In order for these to be applied for clinical use, they require to be formulated with delivery systems. However, there are limited in vi
Autor:
Fabiola Giusti, Giulia Anderluzzi, Russell N. Johnson, Stuart Woods, Simona Gallorini, Barbara Baudner, Ilaria Ferlenghi, Signe Tandrup Schmidt, Derek T. O'Hagan, Gustavo Lou, Michela Brazzoli, Craig W. Roberts, Yvonne Perrie
Publikováno v:
Journal of Controlled Release
Self-amplifying RNA (SAM) represents a versatile tool that can be used to develop potent vaccines, potentially able to elicit strong antigen-specific humoral and cellular-mediated immune responses to virtually any infectious disease. To protect the S
Autor:
Anja Seubert, Derek T. O'Hagan, Bruno Galletti, Alicja Misiak, Kingston H. G. Mills, Mariagrazia Pizza, Aideen C. Allen, Rosanna Leuzzi, Barbara Baudner, Ugo D'Oro
Publikováno v:
Vaccine. 35:5256-5263
A resurgence of whooping cough (pertussis) has been observed in recent years in a number of developed countries, despite widespread vaccine coverage. Although the exact reasons of the recurrence of pertussis are not clear, there are a number of poten
Autor:
Simona Gallorini, Barbara Baudner, Cristiana Balocchi, Derek T. O'Hagan, Francesco Berti, Agnese Donadei, Luigi Panza, Maria Romano, Roberto Adamo
Publikováno v:
Vaccine. 35:3930-3937
Intradermal vaccine delivery is a promising alternative to the conventional intramuscular route. The skin layer is immunologically supported by a densely network of antigen presenting cells, while the skeletal muscle is loaded with a relatively spars
Autor:
Roshan Goswami, Barbara Baudner, Derek T. O'Hagan, Roberto Adamo, Ilaria Ferlenghi, Francesco Berti, Simona Gallorini, Alessandra Bonci, Marianna Taccone, Despo Chatzikleanthous, Gustavo Lou, Michela Brazzoli, Fabiola Giusti, Carlo Pergola
Publikováno v:
ACS Infectious Diseases
Mannosylation of Lipid Nanoparticles (LNP) can potentially enhance uptake by Antigen Presenting Cells, which are highly abundant in dermal tissues, to improve the potency of Self Amplifying mRNA (SAM) vaccines in comparison to the established unmodif
Publikováno v:
Pharmaceutics
Volume 13
Issue 2
Pharmaceutics, Vol 13, Iss 240, p 240 (2021)
Volume 13
Issue 2
Pharmaceutics, Vol 13, Iss 240, p 240 (2021)
Recent approval of mRNA vaccines to combat COVID-19 have highlighted the potential of this platform. Lipid nanoparticles (LNP) is the delivery vehicle of choice for mRNA as they prevent its enzymatic degradation by encapsulation. We have recently sho
The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine
Autor:
Agnese Donadei, Roberto Adamo, Daniela Proietti, Simona Gallorini, Francesca Mancini, Ugo D'Oro, Francesco Berti, Barbara Baudner, Derek T. O'Hagan, Cristiana Balocchi
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 107:110-119
Conjugation of a small molecule immunopotentiator to antigens has been proposed to deliver the ligand to the receptor, localize its action and minimize systemic inflammation. However, the effect of conjugation of Toll like receptor 7 agonists (TLR7a)